Analysts Are Updating Their Scientex Berhad (KLSE:SCIENTX) Estimates After Its Annual Results

It's been a good week for Scientex Berhad (KLSE:SCIENTX) shareholders, because the company has just released its latest annual results, and the shares gained 4.2% to RM4.25. Results were roughly in line with estimates, with revenues of RM4.5b and statutory earnings per share of RM0.35. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Scientex Berhad after the latest results.

Check out our latest analysis for Scientex Berhad

Taking into account the latest results, the consensus forecast from Scientex Berhad's seven analysts is for revenues of RM4.85b in 2025. This reflects a decent 8.4% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to accumulate 8.9% to RM0.38. Yet prior to the latest earnings, the analysts had been anticipated revenues of RM4.78b and earnings per share (EPS) of RM0.38 in 2025. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.

It will come as no surprise then, to learn that the consensus price target is largely unchanged at RM4.69. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic Scientex Berhad analyst has a price target of RM5.48 per share, while the most pessimistic values it at RM4.15. Even so, with a relatively close grouping of estimates, it looks like the analysts are quite confident in their valuations, suggesting Scientex Berhad is an easy business to forecast or the the analysts are all using similar assumptions.

Of course, another way to look at these forecasts is to place them into context against the industry itself. The analysts are definitely expecting Scientex Berhad's growth to accelerate, with the forecast 8.4% annualised growth to the end of 2025 ranking favourably alongside historical growth of 5.8% per annum over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 6.0% annually. Factoring in the forecast acceleration in revenue, it's pretty clear that Scientex Berhad is expected to grow much faster than its industry.

The Bottom Line

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have estimates - from multiple Scientex Berhad analysts - going out to 2027, and you can see them free on our platform here.

Don't forget that there may still be risks. For instance, we've identified 1 warning sign for Scientex Berhad that you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.